October 19, 2020
Last month, the CDC launched a prostate cancer information program with a uniquely digital face: a "virtual human" named Nathan who speaks with men about screening and treatment.
"Talk to Someone About Prostate Cancer" takes the form of an in-browser interactive video developed by health simulation company Kognito, where Nathan introduces himself and prompts the viewer by asking how confident...
Above photo: (From left) Dr Huren Sivaraj, CEO and Co-founder & Ruslan Enikeev, CTO and Co-Founder, Oncoshot.
September 9, 2020
Singapore medical start-up Oncoshot has launched Project EISE (Enhanced Clinical Trial Initiation, Screening and Enrolment), the country’s first nationwide collaborative effort connecting cancer patients, healthcare professionals, as well as pharmaceutical and biotechnology companies via its clinical trial matching platform.
The initiative serves as a bridge between its private and public sector...
January 6, 2020
Cancer has been the leading cause of death in Japan since 1981 and this is compounded by the fact that the country has a hyper-aging society, which means that Japan will face a substantial increase in the number of elderly cancer patients, according to a review article by Matsuda and Saika published in the Annals of Cancer Epidemiology in 2018. Prof Yasushi Goto of the National Cancer Center...
August 6, 2019
Paris, France-based Voluntis has received FDA marketing authorization for an algorithm-driven digital tool that helps cancer patients manage their symptoms and care teams identify clinical insights, the company announced last week.
The Oleena software is a Class II medical device that is prescribed by the patient’s care team. As the user logs their symptoms into the app, it adapts to offer...
March 27, 2019
Direct-to-consumer gene tests like Ancestry.com and 23andMe are increasingly informing consumers about gene alterations that could signal health risks. But those tests look at only a few positions on particular genes, as opposed to medical sequencing that is much more thorough. And, according to a 2018 study by Ambry Genetics in Genetics in Medicine, these results can be wrong — the study showed...
September 7, 2018
Yesterday marked the launch of Driver, a mobile app designed to link cancer patients to appropriate treatment or relevant clinical trials. The app boasts a network of more than 30 global cancer centers, including the US National Cancer Institute, the Cleveland Clinic, and the Chinese National Cancer Center.
"In a world of Amazon, Airbnb, and other technology platforms that have revolutionized our...
June 25, 2018
A prospective cohort study of 33 adolescent cancer patients suggests that providing a Fitbit activity tracker and an iPad equipped with specialized health apps at the time of diagnosis can increase at least subjective measures of quality of life.
In the study, recently published in the Journal of Adolescent and Young Adult Oncology, patients at Stanford Hospital and Clinics and Lucile Packard...
March 19, 2018
Correction: An earlier version of this story included an incorrect funding amount received by OncoPower.
A new platform exclusively for cancer patients is now registering new users. Witty Healthy's newly launched platform, called OncoPower, uses blockchain technology to help patients keep track of their medical data across providers and offer users incentives.
“Typically when a patient gets...
October 18, 2017
Two years after launching its smoking cessation app Quitter's Circle, pharmaceutical company Pfizer is seeing impressive continued engagement with the app. It's also applying the lessons learned from Quitter's Circle toward other mobile health pursuits — including a recently-launched app for people living with cancer.
"We can do surveys right in the app," Mark Pizzini, Pfizer's digital strategy...
January 21, 2016
Cedars-Sinai Medical Center is embarking on a small study to see if a Fitbit Charge HR can help oncologists assess whether their patients are active enough for chemotherapy.
“What we know is that individuals who are up and about tend to be more able to tolerate chemotherapy and have a greater potential for benefitting from it,” Dr. Arvind Shinde, a faculty physician in the departments of...